New shot aims to help cancer patients eat and gain weight
Symptom relief
Recruiting now
This early-stage study tests a new injection called SXRN in 54 adults with advanced cancer who are losing weight and appetite. The main goal is to check safety and find the best dose. Researchers will also see if it helps improve appetite and weight when used alone or with standa…
Phase: PHASE1 • Sponsor: Jiangsu Nutai Biologics Co., Ltd • Aim: Symptom relief
Last updated May 17, 2026 05:08 UTC